Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3010% below fair value
$3.17−0.02 (-0.63%)
Close on Nov 18, 2026Market cap $1.17BP/E 15.8Yield –
Cronos gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Cronos's gross profit for the twelve months ending Jun 30, 2026 was $82.13M, up 92.5% year over year. For fiscal 2025 it was $62.76M, up 149.1% from the year before. The highest annual figure on record is $62.76M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $62.76M | +149.1% |
| FY2024 | Dec 31, 2024 | $25.20M | +111.6% |
| FY2023 | Dec 31, 2023 | $11.91M | -22.8% |
| FY2022 | Dec 31, 2022 | $15.44M | – |
| FY2021 | Dec 31, 2021 | -$17.59M | – |
| FY2020 | Dec 31, 2020 | -$25.83M | – |
| FY2019 | Dec 31, 2019 | -$17.60M | -383.2% |
| FY2018 | Dec 31, 2018 | $6.21M | +294.7% |
| FY2017 | Dec 31, 2017 | $1.57M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $28.45M | +96.2% |
| Q1 FY2026 | Mar 31, 2026 | $19.15M | +39.5% |
| Q4 FY2025 | Dec 31, 2025 | $16.19M | +49.8% |
| Q3 FY2025 | Sep 30, 2025 | $18.33M | +407.7% |
| Q2 FY2025 | Jun 30, 2025 | $14.50M | +130.3% |
| Q1 FY2025 | Mar 31, 2025 | $13.73M | +206.4% |
| Q4 FY2024 | Dec 31, 2024 | $10.81M | +464.9% |
| Q3 FY2024 | Sep 30, 2024 | $3.61M | -9.0% |
| Q2 FY2024 | Jun 30, 2024 | $6.30M | +103.2% |
| Q1 FY2024 | Mar 31, 2024 | $4.48M | +53.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.91M | +51.8% |
| Q3 FY2023 | Sep 30, 2023 | $3.97M | +26.3% |
| Q2 FY2023 | Jun 30, 2023 | $3.10M | -28.3% |
| Q1 FY2023 | Mar 31, 2023 | $2.93M | -57.7% |
| Q4 FY2022 | Dec 31, 2022 | $1.26M | -33.1% |
| Q3 FY2022 | Sep 30, 2022 | $3.14M | – |
| Q2 FY2022 | Jun 30, 2022 | $4.32M | – |
| Q1 FY2022 | Mar 31, 2022 | $6.93M | – |
| Q4 FY2021 | Dec 31, 2021 | $1.88M | – |
| Q3 FY2021 | Sep 30, 2021 | -$730.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$15.78M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.96M | – |
| Q4 FY2020 | Dec 31, 2020 | -$14.90M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.54M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.92M | -171.4% |
| Q1 FY2020 | Mar 31, 2020 | -$6.48M | -516.5% |
| Q4 FY2019 | Dec 31, 2019 | -$20.38M | -1183.8% |
| Q3 FY2019 | Sep 30, 2019 | -$3.14M | -297.9% |
| Q2 FY2019 | Jun 30, 2019 | $4.09M | +146.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.56M | +42.7% |
| Q4 FY2018 | Dec 31, 2018 | $1.88M | – |
| Q3 FY2018 | Sep 30, 2018 | $1.59M | – |
| Q2 FY2018 | Jun 30, 2018 | $1.66M | – |
| Q1 FY2018 | Mar 31, 2018 | $1.09M | – |
See a number that looks wrong?